(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.

@article{Buchmann201618FFluoroethyllThyrosinePE,
  title={(18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.},
  author={N. Buchmann and Benjamin Kl{\"a}sner and J. Gempt and J. Bauer and T. Pyka and C. Delbridge and B. Meyer and B. Krause and F. Ringel},
  journal={World neurosurgery},
  year={2016},
  volume={89},
  pages={
          420-6
        }
}
  • N. Buchmann, Benjamin Kläsner, +6 authors F. Ringel
  • Published 2016
  • Medicine
  • World neurosurgery
  • OBJECTIVE Complete resection of contrast-enhancing tumor is an important prognostic factor in glioblastoma therapy. The current clinical standard for control of resection is magnetic resonance imaging (MRI). (18)F-Fluoroethyl-l-thyrosine (FET) is a positron emission tomography (PET) radiopharmaceutical applicable for widespread use because of its long half-life radionuclide. We assessed the sensitivity of postoperative MRI versus FET-PET to detect residual tumor and the impact of the time… CONTINUE READING
    16 Citations
    Flare Phenomenon in O-(2-18F-Fluoroethyl)-l-Tyrosine PET After Resection of Gliomas
    • 2
    9 PET Imaging in Glioblastoma : Use in Clinical Practice
    Advantages and limitations of amino acid PET for tracking therapy response in glioma patients
    • 1

    References

    SHOWING 1-10 OF 31 REFERENCES
    Prognostic impact of postoperative, pre-irradiation (18)F-fluoroethyl-l-tyrosine uptake in glioblastoma patients treated with radiochemotherapy.
    • M. Piroth, R. Holý, +7 authors K. J. Langen
    • Medicine
    • Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
    • 2011
    • 66
    Value of O-(2-[18F]fluoroethyl)-l-tyrosine PET for the diagnosis of recurrent glioma
    • 240
    Clinical Applications of PET in Brain Tumors*
    • W. Chen
    • Medicine
    • Journal of Nuclear Medicine
    • 2007
    • 357
    • PDF